UB Paderborn / Katalog / Suche / in CDI

The amylase inhibitor montbretin A reveals a new glycosidase inhibition motif

Nature chemical biology, 2015-09, Vol.11 (9), p.691

2015

Volltextzugriff (PDF)

Multi-parametric MRI at 14T for muscular dystrophy mice treated with AAV vector-mediated gene therapy

PloS one, 2015-04, Vol.10 (4), p.e0124914-e0124914

2015

Volltextzugriff (PDF)

Efficacy and muscle safety assessment of fukutin-related protein gene therapy

Molecular therapy. Methods & clinical development, 2023-09, Vol.30, p.65-80

2023

Volltextzugriff (PDF)

Potent Human α‑Amylase Inhibition by the β‑Defensin-like Protein Helianthamide

ACS central science, 2016-03, Vol.2 (3), p.154-161

2016

Volltextzugriff (PDF)

Synthesis of lipophilic 1-deoxygalactonojirimycin derivatives as D-galactosidase inhibitors

Beilstein journal of organic chemistry, 2010-03, Vol.6 (1), p.21-21

2010

Volltextzugriff (PDF)

A New, Simple, High-Affinity Glycosidase Inhibitor: Analysis of Binding through X-ray Crystallography, Mutagenesis, and Kinetic Analysis

Journal of the American Chemical Society, 2000-05, Vol.122 (17), p.4229-4230

2000

Volltextzugriff (PDF)

Transition-State Mimicry by Glycosidase Inhibitors: A Critical Kinetic Analysis

Journal of the American Chemical Society, 2007-04, Vol.129 (15), p.4530-4531

2007

Volltextzugriff (PDF)

Development of a Clinical AAV-Based Vector Encoding a Microdystrophin Transgene for the Treatment of Duchenne Muscular Dystrophy

Molecular therapy, 2013-09, Vol.21 (9), p.e17-e17

2013

Volltextzugriff (PDF)

Circular Permutation of Bacillus circulans Xylanase: A Kinetic and Structural Study

Biochemistry (Easton), 2010-03, Vol.49 (11), p.2464-2474

2010

Volltextzugriff (PDF)

Recruitment of Both Uniform and Differential Binding Energy in Enzymatic Catalysis: Xylanases from Families 10 and 11

Biochemistry (Easton), 2007-06, Vol.46 (23), p.6996-7005

2007

Volltextzugriff (PDF)

A fluorescent probe for GM1 gangliosidosis related β-galactosidase: N-(Dansylamino)hexylaminocarbonylpentyl-1,5-dideoxy-1,5-imino- d-galactitol

Bioorganic & medicinal chemistry letters, 2011-11, Vol.21 (22), p.6872-6875

2011

Volltextzugriff (PDF)

1-Deoxy-d-galactonojirimycins with dansyl capped N-substituents as β-galactosidase inhibitors and potential probes for GM1 gangliosidosis affected cell lines

Carbohydrate research, 2011-09, Vol.346 (12), p.1592-1598

2011

Volltextzugriff (PDF)

A fluorescent probe for GM1 gangliosidosis related I super(2)-galactosidase: N-(Dansylamino)hexylaminocarbonylpentyl-1,5-dideoxy-1,5-imino-d-ga l actitol

Bioorganic & medicinal chemistry letters, 2011-11, Vol.21 (22), p.6872-6875

2011

Volltextzugriff (PDF)

Multi-Parametric MRI at 14T for Muscular Dystrophy Mice Treated with AAV Vector-Mediated Gene Therapy: e0124914

PloS one, 2015-04, Vol.10 (4)

2015

Volltextzugriff (PDF)

Probing Electrostatic Interactions along the Reaction Pathway of a Glycoside Hydrolase: Histidine Characterization by NMR Spectroscopy

Biochemistry (Easton), 2007-06, Vol.46 (25), p.7383-7395

2007

Volltextzugriff (PDF)

A fluorescent probe for GM1 gangliosidosis related β-galactosidase: N-(Dansylamino)hexylaminocarbonylpentyl-1,5-dideoxy-1,5-imino-n-galactitol

Bioorganic & medicinal chemistry letters, 2011, Vol.21 (22), p.6872-6875

2011

Volltextzugriff (PDF)

Trapping covalent intermediates on β-glycosidases

Enzyme Kinetics and Mechanism, Part F: Detection and Characterization of Enzyme Reaction Intermediates, 2002, Vol.354, p.84-105

2002

Volltextzugriff (PDF)

1-Deoxynojirimycins with dansyl capped N-substituents as probes for Morbus Gaucher affected cell lines

Carbohydrate research, 2010-07, Vol.345 (10), p.1371-1376

2010

Volltextzugriff (PDF)

A Case for Reverse Protonation: Identification of Glu160 as an Acid/Base Catalyst in Thermoanaerobacterium saccharolyticum β-Xylosidase and Detailed Kinetic Analysis of a Site-Directed Mutant

Biochemistry (Easton), 2002-08, Vol.41 (31), p.9736-9746

2002

Volltextzugriff (PDF)

Mechanism of Thermoanaerobacterium saccharolyticum β-Xylosidase: Kinetic Studies

Biochemistry (Easton), 2002-08, Vol.41 (31), p.9727-9735

2002

Volltextzugriff (PDF)

Animal Models of Muscular Dystrophy

Animal Models of Molecular Pathology, 2012, Vol.105, p.83-111

2012

Volltextzugriff (PDF)

Gas Phase Noncovalent Protein Complexes that Retain Solution Binding Properties: Binding of Xylobiose Inhibitors to the β-1, 4 Exoglucanase from Cellulomonas fimi

Journal of the American Society for Mass Spectrometry, 2007, Vol.18 (1), p.64-73

2007

Volltextzugriff (PDF)

Atomic resolution analyses of the binding of xylobiose-derived deoxynojirimycin and isofagomine to xylanase Xyn10A

Chemical communications (Cambridge, England), 2004-08 (16), p.1794-1795

2004

Volltextzugriff (PDF)

Gas phase noncovalent protein complexes that retain solution binding properties: Binding of xylobiose inhibitors to the [beta]-1, 4 exoglucanase from Cellulomonas fimi

Journal of the American Society for Mass Spectrometry, 2007-01, Vol.18 (1), p.64

2007

Volltextzugriff (PDF)

Insights into the catalytic mechanism of a retaining xylanase from Cellulomonas fimi

Wicki, Jacqueline

2007

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

The amylase inhibitor montbretin A reveals a new glycosidase inhibition motif

Multi-parametric MRI at 14T for muscular dystrophy mice treated with AAV vector-mediated gene therapy

Efficacy and muscle safety assessment of fukutin-related protein gene therapy

Potent Human α‑Amylase Inhibition by the β‑Defensin-like Protein Helianthamide

Synthesis of lipophilic 1-deoxygalactonojirimycin derivatives as D-galactosidase inhibitors

A New, Simple, High-Affinity Glycosidase Inhibitor: Analysis of Binding through X-ray Crystallography, Mutagenesis, and Kinetic Analysis

Transition-State Mimicry by Glycosidase Inhibitors: A Critical Kinetic Analysis

Development of a Clinical AAV-Based Vector Encoding a Microdystrophin Transgene for the Treatment of Duchenne Muscular Dystrophy

Circular Permutation of Bacillus circulans Xylanase: A Kinetic and Structural Study

Recruitment of Both Uniform and Differential Binding Energy in Enzymatic Catalysis: Xylanases from Families 10 and 11

A fluorescent probe for GM1 gangliosidosis related β-galactosidase: N-(Dansylamino)hexylaminocarbonylpentyl-1,5-dideoxy-1,5-imino- d-galactitol

1-Deoxy-d-galactonojirimycins with dansyl capped N-substituents as β-galactosidase inhibitors and potential probes for GM1 gangliosidosis affected cell lines

A fluorescent probe for GM1 gangliosidosis related I super(2)-galactosidase: N-(Dansylamino)hexylaminocarbonylpentyl-1,5-dideoxy-1,5-imino-d-ga l actitol

Multi-Parametric MRI at 14T for Muscular Dystrophy Mice Treated with AAV Vector-Mediated Gene Therapy: e0124914

Probing Electrostatic Interactions along the Reaction Pathway of a Glycoside Hydrolase: Histidine Characterization by NMR Spectroscopy

A fluorescent probe for GM1 gangliosidosis related β-galactosidase: N-(Dansylamino)hexylaminocarbonylpentyl-1,5-dideoxy-1,5-imino-n-galactitol

Trapping covalent intermediates on β-glycosidases

1-Deoxynojirimycins with dansyl capped N-substituents as probes for Morbus Gaucher affected cell lines

A Case for Reverse Protonation: Identification of Glu160 as an Acid/Base Catalyst in Thermoanaerobacterium saccharolyticum β-Xylosidase and Detailed Kinetic Analysis of a Site-Directed Mutant

Mechanism of Thermoanaerobacterium saccharolyticum β-Xylosidase: Kinetic Studies

Animal Models of Muscular Dystrophy

Gas Phase Noncovalent Protein Complexes that Retain Solution Binding Properties: Binding of Xylobiose Inhibitors to the β-1, 4 Exoglucanase from Cellulomonas fimi

Atomic resolution analyses of the binding of xylobiose-derived deoxynojirimycin and isofagomine to xylanase Xyn10A

Gas phase noncovalent protein complexes that retain solution binding properties: Binding of xylobiose inhibitors to the [beta]-1, 4 exoglucanase from Cellulomonas fimi

Insights into the catalytic mechanism of a retaining xylanase from Cellulomonas fimi

Suchergebnisse filtern